Study highlights a widespread, often silent condition
A new study published in The Lancet has raised concerns about fatty liver disease in India, estimating that nearly four in 10 people in the country may be affected by the condition even when alcohol is not the cause. The findings, reported by NDTV, point to a significant health burden that can go unnoticed for long periods.
Fatty liver disease refers to excess fat accumulation in the liver. When it occurs without alcohol being the driver, it is commonly described as non-alcohol-related fatty liver disease. The Lancet estimate suggests the condition could be far more common in India than many people realise.
Why the estimate is drawing attention
The scale of the number is the key concern. If up to 40% of Indians are affected, it indicates that fatty liver disease is not limited to a small, high risk group but may be present across a wide section of the population.
Health experts often describe fatty liver as a silent problem because it may not produce clear symptoms early on. This means many people may not know they have it until it is detected during routine checks or when complications develop.
Public health implications
The report frames the situation as a potential public health crisis due to both prevalence and the likelihood of under diagnosis. With such a large possible affected population, early identification and monitoring become critical for health systems.
The study estimate also underlines the need for wider awareness that fatty liver disease can occur even in people who do not consume alcohol, and that liver health risks are not confined to alcohol related illness.
What the report says about India
According to the NDTV report citing The Lancet study, the high proportion of cases indicates a broad national challenge. The findings are being seen as an alarm bell for policymakers and healthcare providers because the burden could translate into large numbers of people requiring medical guidance and follow up over time.
The report does not attribute the estimate to alcohol use, focusing instead on fatty liver disease that is unrelated to alcohol. This distinction is important because it widens the potential risk group well beyond people with alcohol consumption habits.